NCT01428531View on ClinicalTrials.gov

Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Ataxia

Interventions

DRUG

Fondaparinux Sodium

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY